The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2

Autor: Skrypek N, Vasseur R, Vincent A, Belinda Duchêne, Van Seuningen I, Jonckheere N
Zdroj: Europe PubMed Central
Databáze: OpenAIRE